The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

TORONTO, ON / ACCESSWIRE / / ProteinQure, a leader in computational peptide design, is proud to announce the addition of two ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and ...

Researchers are developing the world’s first topical cream to prevent and treat skin cancer, especially for organ transplant ...

Adults working with pre-school children need to have a knowledge of child development and what is expected at each level of development, for example approximately what age babies start to walk, talk ...

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company”, an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is ...

Aadi Bioscience has rebooted its operations, transforming from a commercial business into a preclinical biotech ... and committing up to $265 million in development milestones and $540 million ...

to advance pre-clinical development of Shuttle Diagnostics, Inc.’s (a wholly-owned subsidiary of Shuttle Pharma) ligand to the prostate-specific membrane antigen (PSMA) as a potential diagnostic and ...

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a preclinical ... science-driven business development to augment and ...

The NF Preclinical Hub continues this momentum ... Screening therapies to validate the model for drug development. Once validated, the model will be made available to researchers worldwide ...